معرفی
Emma Aarnio is a Senior Researcher at the School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland. Her work focuses on pharmacoeconomics, pharmacoepidemiology, and medication adherence research, particularly in chronic disease management such as type 2 diabetes and cardiovascular conditions. She is affiliated with the Pharmaceutical Policy Research Group and Pharmacoeconomics and Outcomes Research Group, contributing to national and international projects like the GuideGap and ENABLE COST Action.
Research Interests
- Pharmacoeconomic modeling of preventive interventions
- Medication persistence and adherence mechanisms
- Population-level impact of drug reimbursement policies
- Pharmacoepidemiology using national registers
- Health-related quality of life assessments
- Pharmaceutical care in diabetes risk reduction
Recent Article Trends
Emma's 15 most recent publications (2025-2023) emphasize real-world effectiveness of medication adherence interventions, cost-utility analyses of diabetes prevention programs, and register-based studies on cardiovascular drug persistence. Key themes include type 2 diabetes screening, pharmacist-led public health initiatives, and socioeconomic factors in drug therapy.Projects & Collaborations
Current projects include the GuideGap study on guideline-adherent prescribing and Media Visibility of Medicines research. She contributes to the House of Effectiveness initiative and previously participated in the StopDia diabetes prevention program, demonstrating expertise in community pharmacy interventions and digital health economics.۰مقاله ثبتشده
